Genomics Institute of the Novartis Research Foundation
2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
Novel pyrimidine derivatives of formula Ito processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.
IRM LLC Novartis AG
A A A A A A A A A A A C A A A A A C C A A C A C C A A A A A A A A C A A
A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P C07D A61P A61P A61P A61P A61P C04B C07D A61P A61P C07D A61P C07D C07D A61P A61P A61P A61P A61P A61P A61P A61P C07D A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Eiji Qiang Yongqin Qiong Ruo Greg Carlos Naoko Jiqing Osamu Ichiro Donald Takahiro Nathanael Schiander Keiichi Takanori
Kawahara Ding Wan Zhang Steensma Chopiuk Garcia-Echeverria Matsuura Jiang Ohmori Umemura Karanewsky Miyake Gray Masuya Kanazawa